|
1
|
da Rocha AB, Lopes RM and Schwartsmann G:
Natural products in anticancer therapy. Curr Opin Pharmacol.
1:364–369. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mann J: Natural products in cancer
chemotherapy: Past, present and future. Nat Rev Cancer. 2:143–148.
2002. View
Article : Google Scholar
|
|
3
|
Koehn FE and Carter GT: The evolving role
of natural products in drug discovery. Nat Rev Drug Discov.
4:206–220. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Corson TW and Crews CM: Molecular
understanding and modern application of traditional medicines:
Triumphs and trials. Cell. 130:769–774. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang HL, Zhang XH and Chang TH: Effects of
tetrandrine on smooth muscle contraction induced by mediators in
pulmonary hypertension. Acta Pharmacol Sin. 23:1114–1120.
2002.PubMed/NCBI
|
|
6
|
Jiang J and Hu C: Evodiamine: A novel
anti-cancer alkaloid from Evodia rutaecarpa. Molecules.
14:1852–1859. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu H, Jin H, Gong W, Wang Z and Liang H:
Pharmacological actions of multi-target-directed evodiamine.
Molecules. 18:1826–1843. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hong JY, Park SH, Min HY, Park HJ and Lee
SK: Anti-proliferative effects of evodiamine in human lung cancer
cells. J Cancer Prev. 19:7–13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chien CC, Wu MS, Shen SC, Ko CH, Chen CH,
Yang LL and Chen YC: Activation of JNK contributes to
evodiamine-induced apoptosis and G2/M arrest in human colorectal
carcinoma cells: A structure-activity study of evodiamine. PLoS
One. 9:e997292014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du J, Wang XF, Zhou QM, Zhang TL, Lu YY,
Zhang H and Su SB: Evodiamine induces apoptosis and inhibits
metastasis in MDA-MB-231 human breast cancer cells in vitro and in
vivo. Oncol Rep. 30:685–694. 2013.PubMed/NCBI
|
|
11
|
Wang KL, Hsia SM, Yeh JY, Cheng SC, Wang
PS and Wang SW: Anti-Proliferative Effects of evodiamine on human
breast cancer cells. PLoS One. 8:e672972013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pugh CW, O'Rourke JF, Nagao M, Gleadle JM
and Ratcliffe PJ: Activation of hypoxia-inducible factor-1;
definition of regulatory domains within the alpha subunit. J Biol
Chem. 272:11205–11214. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Palazon A, Goldrath AW, Nizet V and
Johnson RS: HIF transcription factors, inflammation, and immunity.
Immunity. 41:518–528. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Semenza GL: Defining the role of
hypoxia-inducible factor 1 in cancer biology and therapeutics.
Oncogene. 29:625–634. 2010. View Article : Google Scholar :
|
|
15
|
Sun HL, Liu YN, Huang YT, Pan SL, Huang
DY, Guh JH, Lee FY, Kuo SC and Teng CM: YC-1 inhibits HIF-1
expression in prostate cancer cells: Contribution of Akt/NF-kappaB
signaling to HIF-1alpha accumulation during hypoxia. Oncogene.
26:3941–3951. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
He BC, Gao JL, Zhang BQ, Luo Q, Shi Q, Kim
SH, Huang E, Gao Y, Yang K, Wagner ER, et al: Tetrandrine inhibits
Wnt/β-catenin signaling and suppresses tumor growth of human
colorectal cancer. Mol Pharmacol. 79:211–219. 2011. View Article : Google Scholar :
|
|
17
|
He TC, Zhou S, da Costa LT, Yu J, Kinzler
KW and Vogelstein B: A simplified system for generating recombinant
adenoviruses. Proc Natl Acad Sci USA. 95:2509–2514. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo J, Deng ZL, Luo X, Tang N, Song WX,
Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, et al: A protocol
for rapid generation of recombinant adenoviruses using the AdEasy
system. Nat Protoc. 2:1236–1247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
El Naggar A, Clarkson P, Zhang F, Mathers
J, Tognon C and Sorensen PH: Expression and stability of hypoxia
inducible factor 1α in osteosarcoma. Pediatr Blood Cancer.
59:1215–1222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He BC, Gao JL, Luo X, Luo J, Shen J, Wang
L, Zhou Q, Wang YT, Luu HH, Haydon RC, et al: Ginsenoside Rg3
inhibits colorectal tumor growth through the down-regulation of
Wnt/ß-catenin signaling. Int J Oncol. 38:437–445. 2011. View Article : Google Scholar
|
|
21
|
Zhang C, Fan X, Xu X, Yang X, Wang X and
Liang HP: Evodiamine induces caspase-dependent apoptosis and S
phase arrest in human colon LoVo cells. Anticancer Drugs.
21:766–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ogasawara M, Matsubara T and Suzuki H:
Inhibitory effects of evodiamine on in vitro invasion and
experimental lung metastasis of murine colon cancer cells. Biol
Pharm Bull. 24:917–920. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leonardi E, Girlando S, Serio G, Mauri FA,
Perrone G, Scampini S, Dalla Palma P and Barbareschi M: PCNA and
Ki67 expression in breast carcinoma: Correlations with clinical and
biological variables. J Clin Pathol. 45:416–419. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang SC: PCNA: A silent housekeeper or a
potential therapeutic target? Trends Pharmacol Sci. 35:178–186.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vermes I, Haanen C, Steffens-Nakken H and
Reutelingsperger C: A novel assay for apoptosis. Flow cytometric
detection of phosphatidylserine expression on early apoptotic cells
using fluorescein labelled Annexin V. J Immunol Methods. 184:39–51.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Walters J, Pop C, Scott FL, Drag M, Swartz
P, Mattos C, Salvesen GS and Clark AC: A constitutively active and
uninhibitable caspase-3 zymogen efficiently induces apoptosis.
Biochem J. 424:335–345. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Formenti F, Constantin-Teodosiu D,
Emmanuel Y, Cheeseman J, Dorrington KL, Edwards LM, Humphreys SM,
Lappin TR, McMullin MF, McNamara CJ, et al: Regulation of human
metabolism by hypoxia-inducible factor. Proc Natl Acad Sci USA.
107:12722–12727. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Benizri E, Ginouvès A and Berra E: The
magic of the hypoxia-signaling cascade. Cell Mol Life Sci.
65:1133–1149. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Macarulla T, Sauri T and Tabernero J:
Evaluation of aflibercept in the treatment of metastatic colorectal
cancer. Expert Opin Biol Ther. 14:1493–1505. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gasparini G, Buttitta F, D'Andrea MR,
Tumolo S, Buonadonna A, Pavese I, Cordio S, De Tursi M, Mosconi S,
Stumbo L, et al: Optimizing single agent panitumumab therapy in
pre-treated advanced colorectal cancer. Neoplasia. 16:751–756.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Semenza GL: Hypoxia-inducible factors in
physiology and medicine. Cell. 148:399–408. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vaupel P, Mayer A and Höckel M: Tumor
hypoxia and malignant progression. Methods Enzymol. 381:335–354.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hoffmann AC, Mori R, Vallbohmer D,
Brabender J, Klein E, Drebber U, Baldus SE, Cooc J, Azuma M,
Metzger R, et al: High expression of HIF1a is a predictor of
clinical outcome in patients with pancreatic ductal adenocarcinomas
and correlated to PDGFA, VEGF, and bFGF. Neoplasia. 10:674–679.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu Y, Lucia K, Lange M, Kuhlen D, Stalla
GK and Renner U: Hypoxia inducible factor-1 is involved in growth
factor, glucocorticoid and hypoxia mediated regulation of vascular
endothelial growth factor-A in human meningiomas. J Neurooncol.
119:263–273. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
van Uden P, Kenneth NS and Rocha S:
Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem
J. 412:477–484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ma X and Bai Y: IGF-1 activates the
P13K/AKT signaling pathway via upregulation of secretory clusterin.
Mol Med Rep. 6:1433–1437. 2012.PubMed/NCBI
|
|
37
|
Song MS, Salmena L and Pandolfi PP: The
functions and regulation of the PTEN tumour suppressor. Nat Rev Mol
Cell Biol. 13:283–296. 2012.PubMed/NCBI
|
|
38
|
Zhu C, Qi X, Chen Y, Sun B, Dai Y and Gu
Y: PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in
IGF-1-induced VEGF-C upregulation in breast cancer. J Cancer Res
Clin Oncol. 137:1587–1594. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Blanco-Aparicio C, Renner O, Leal JF and
Carnero A: PTEN, more than the AKT pathway. Carcinogenesis.
28:1379–1386. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gluckman P, Klempt N, Guan J, Mallard C,
Sirimanne E, Dragunow M, Klempt M, Singh K, Williams C and Nikolics
K: A role for IGF-1 in the rescue of CNS neurons following
hypoxic-ischemic injury. Biochem Biophys Res Commun. 182:593–599.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Valentinis B and Baserga R: IGF-I receptor
signalling in transformation and differentiation. Mol Pathol.
54:133–137. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fu P, Thompson JA, Leeding KS and Bach LA:
Insulin-like growth factors induce apoptosis as well as
proliferation in LIM 1215 colon cancer cells. J Cell Biochem.
100:58–68. 2007. View Article : Google Scholar
|
|
43
|
LeRoith D, Werner H, Beitner-Johnson D and
Roberts CT Jr: Molecular and cellular aspects of the insulin-like
growth factor I receptor. Endocr Rev. 16:143–163. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
LeRoith D and Roberts CT Jr: The
insulin-like growth factor system and cancer. Cancer Lett.
195:127–137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Weroha SJ and Haluska P: The insulin-like
growth factor system in cancer. Endocrinol Metab Clin North Am.
41:335–350. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang Z, Wang Z, Liang Z, Liu J, Shi W, Bai
P, Lin X, Magaye R and Zhao J: Expression and clinical significance
of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues
from patients with non-small cell lung cancer. Onco Targets Ther.
6:1437–1444. 2013.PubMed/NCBI
|
|
47
|
Chen D, Siddiq A, Emdad L, Rajasekaran D,
Gredler R, Shen XN, Santhekadur PK, Srivastava J, Robertson CL,
Dmitriev I, et al: Insulin-like growth factor-binding protein-7
(IGFBP7): A promising gene therapeutic for hepatocellular carcinoma
(HCC). Mol Ther. 21:758–766. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Vanamala J, Reddivari L, Radhakrishnan S
and Tarver C: Resveratrol suppresses IGF-1 induced human colon
cancer cell proliferation and elevates apoptosis via suppression of
IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer.
10:2382010. View Article : Google Scholar : PubMed/NCBI
|
